AAAAAA
Results: 1-25/108
Authors:
Nunez, M
de Requena, DG
Gallego, L
Jimenez-Nacher, I
Gonzalez-Lahoz, J
Soriano, V
Citation: M. Nunez et al., Higher efavirenz plasma levels correlate with development of insomnia, J ACQ IMM D, 28(4), 2001, pp. 399-399
Authors:
Nunez, M
Lana, R
Mendoza, JL
Martin-Carbonero, L
Soriano, V
Citation: M. Nunez et al., Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy, J ACQ IMM D, 27(5), 2001, pp. 426-431
Authors:
Barreiro, P
Oller, V
Soriano, V
Nunez, M
Rodriguez-Rosado, R
Gonzalez-Lahoz, J
Citation: P. Barreiro et al., Performance of a quadruple combination including nelfinavir plus efavirenzin naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens, J ACQ IMM D, 26(4), 2001, pp. 391-392
Authors:
Briones, C
Perez-Olmeda, M
Rodriguez, C
del Romero, J
Hertogs, K
Soriano, V
Citation: C. Briones et al., Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid, J ACQ IMM D, 26(2), 2001, pp. 145-150
Authors:
Soriano, V
Barreiro, P
de Mendoza, C
Dona, C
Gonzalez-Lahoz, J
Citation: V. Soriano et al., Monthly cyclic therapy in heavily pretreated HIV-infected patients, AIDS PAT CA, 15(4), 2001, pp. 177-179
Authors:
Soriano, V
Martin-Carbonero, L
Garcia-Samaniego, J
Puoti, M
Citation: V. Soriano et al., Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus, CLIN INF D, 33(10), 2001, pp. 1793-1795
Authors:
Nunez, M
Rodriguez-Rosado, R
Soriano, V
Citation: M. Nunez et al., Intensification of antiretroviral therapy, AIDS RES H, 17(6), 2001, pp. 499-506
Authors:
Cilla, G
Rodes, B
Perez-Trallero, E
Arrizabalaga, J
Soriano, V
Citation: G. Cilla et al., Molecular evidence of homosexual transmission of HIV type 2 in Spain, AIDS RES H, 17(5), 2001, pp. 417-422
Authors:
Martin-Carbonero, L
Soriano, V
Valencia, E
Garcia-Samaniego, J
Lopez, M
Gonzalez-Lahoz, J
Citation: L. Martin-carbonero et al., Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients, AIDS RES H, 17(16), 2001, pp. 1467-1471
Authors:
Luk, KC
Kaptue, L
Zekeng, L
Soriano, V
Gurtler, L
Devare, SG
Schochetman, G
Hackett, J
Citation: Kc. Luk et al., Naturally occurring sequence polymorphisms within HIV type 1 group O protease, AIDS RES H, 17(16), 2001, pp. 1555-1561
Authors:
Soriano, V
Citation: V. Soriano, Sequencing antiretroviral drugs, AIDS, 15(5), 2001, pp. 547-551
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Gallego, O
Ruiz, L
Vallejo, A
Ferrer, E
Rubio, A
Clotet, B
Leal, M
Soriano, V
Citation: O. Gallego et al., Changes in the rate of genotypic resistance to antiretroviral drugs in Spain, AIDS, 15(14), 2001, pp. 1894-1896
Authors:
Gallego, O
de Mendoza, C
Perez-Elias, MJ
Guardiola, JM
Pedreira, J
Dalmau, D
Gonzalez, J
Moreno, A
Arribas, JR
Rubio, A
Garcia-Arata, I
Leal, M
Domingo, P
Soriano, V
Citation: O. Gallego et al., Drug resistance in patients experiencing early virological failure under atriple combination including indinavir, AIDS, 15(13), 2001, pp. 1701-1706
Authors:
Machuca, A
Rodes, B
Soriano, V
Citation: A. Machuca et al., The effect of antiretroviral therapy on HTLV infection, VIRUS RES, 78(1-2), 2001, pp. 93-100
Authors:
Rodriguez-Rosado, R
Perez-Olmeda, M
Garcia-Samaniego, J
Soriano, V
Citation: R. Rodriguez-rosado et al., Management of hepatitis C in HIV-infected persons, ANTIVIR RES, 52(2), 2001, pp. 189-198
Authors:
de Mendoza, C
Lu, W
Machuca, A
Sainz, M
Castilla, J
Soriano, V
Citation: C. De Mendoza et al., Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays, J MED VIROL, 64(3), 2001, pp. 217-222
Authors:
Perez-Olmeda, M
Del Romero, J
Rubio, A
Ruiz, L
Rodriguez, C
Leal, M
Clotet, B
Soriano, V
Citation: M. Perez-olmeda et al., Primary HIV-1 drug resistance in spain before and after the introduction of protease inhibitors, J MED VIROL, 63(2), 2001, pp. 85-87
Authors:
Soriano, V
Martin, JC
Gonzalez-Lahoz, J
Citation: V. Soriano et al., HIV-1 progression in hepatitis-C-infected drug users, LANCET, 357(9265), 2001, pp. 1361-1362
Authors:
Barreiro, P
Soriano, V
Gonzalez-Lahoz, J
Citation: P. Barreiro et al., Prevention of nevirapine-associated rash, LANCET, 357(9253), 2001, pp. 392-392
Authors:
Holguin, A
Aracil, B
Alvarez, A
Barros, C
Soriano, V
Citation: A. Holguin et al., Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances ofthe AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5, J CLIN MICR, 39(5), 2001, pp. 1850-1854
Authors:
Swanson, P
Soriano, V
Devare, SG
Hackett, J
Citation: P. Swanson et al., Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) andgroup O: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR version 1.5, andQuantiplex HIV-1 RNA version 3.0, J CLIN MICR, 39(3), 2001, pp. 862-870
Authors:
Gonzalez-Castillo, J
Blanco, F
Soriano, V
Barreiro, P
Bravo, MC
Jimenez-Nacher, I
Gonzalez-Lahoz, J
Citation: J. Gonzalez-castillo et al., Opportunistic events shortly after beginning HAART in HIV-infected patients, MED CLIN, 117(3), 2001, pp. 81-84
Authors:
Lana, R
Nunez, M
Mendoza, JL
Soriano, V
Citation: R. Lana et al., Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy, MED CLIN, 117(16), 2001, pp. 607-610
Authors:
Diaz, B
Nunez, M
Soriano, V
Citation: B. Diaz et al., Acute hepatitis B in a previously vaccined patient infected by the human immunodeficiency virus, MED CLIN, 117(13), 2001, pp. 518-519